Abbreviations AL: Austre Lovénbreen DEM: digital elevation model ELA: equilibrium-line altitude GPS: global positioning system SMB: surface mass balance w.e.: water equivalent Polar Research 2019.
Ice flow velocity is a sensitive indicator of glacier variations both controlling and representing the delivery of ice and affecting the future stability of ice masses in a warming climate. As one of the poly-thermal glaciers in the high Arctic, Austre Lovénbreen (AL) is on the northwestern coast of Spitsbergen, Svalbard. The ice flow velocity of AL was investigated using in situ global positioning system (GPS) observations over 14 years and numerical modelling with Elmer/Ice. First, the ice flow velocity field of AL along central flow line was presented and the ice flow velocity is approximately 4 m/a. Obvious seasonal changes of ice flow velocity can be found in the middle of the glacier, where the velocity in spring-summer is 47% larger than in autumn–winter in 2016, and the mean annual velocity increased 14% from 2009 until 2016. Second, the numerical simulation was performed considering the poly-thermal character of the glacier, and indicated that there are two peak ice flow regions on the glacier, and not just one peak ice flow region as previously believed. The new peak ice flow zone found by simulation was verified by field work, which also demonstrated that the velocity of the newly identified zone is 8% faster than the previously identified zone. Third, although our field observations showed that the ice flow velocity is slowly increasing recently, the maximum ice flow velocity will soon begin to decrease gradually in the long term according to glacier evolution modelling of AL.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.